Compare Globus Medical Inc. Class A Common Stock (GMED) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Kimberly Clark Corp — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Kimberly Clark Corp trades at $102.5 (market cap $33.06B). The key difference: Kimberly Clark Corp is far larger — about 3.2× Globus Medical Inc. Class A Common Stock's market cap, and Kimberly Clark Corp pays a 5.15% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Kimberly Clark Corp for 94 Days on average.
| GMED | KMB | |
|---|---|---|
Market Cap | $10.25B | $33.06B |
Volume | 1,059,528 | 6,233,100 |
Sector | Health | Consumer Staples |
52-Week High | $96.82 | $121.44 |
52-Week Low | $58.33 | $93.05 |
Typical Hold Time | 0 Days | 94 Days |
Enterprise Value | $9.76B | $38.62B |
Dividend Yield | — | 5.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Kimberly-Clark (KMB) trades at $98.29, down 0.49% on the day, showing bearish technical momentum with the stock near key support levels. The company maintains solid profitability with 11.79% net margins and has beaten earnings estimates in 2 of the last 3 quarters. Recent executive transitions and the pending Kenvue acquisition create both opportunities and uncertainties for the consumer staples giant.
KMB offers a compelling 5.2% dividend yield with 54 consecutive years of increases, though cash flow sustainability remains a concern. Analyst consensus targets $117.25 (19% upside) but the stock faces headwinds from integration risks and competitive pressures in the personal care market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
